Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIGen Therapeutics is an Indian biotechnology startup that leverages advanced artificial intelligence and deep learning platforms to discover and develop novel therapies for high-unmet-need genetic and infectious diseases. Founded in 2019 and headquartered in Gurugram, the company operates as a full-stack biotech, combining computational discovery with in-house wet-lab validation and supercomputing power. Its proprietary AI platform analyzes massive proteomic and genomic datasets to design first-in-class biologics, antibodies, and therapeutic peptides. AIGen currently advances a diverse pipeline of candidates through strategic research collaborations with academic institutions, including Panjab University and the NCR Biotech Science Cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AipGene Therapeutics.